Comparison of the therapeotic effects of omega3 fatty acids and Rose damascena on premenstural syndrom

INTERVENTION: In the first group during the 14 days before the start of the next menstruation to menopause, a daily 500 mg of omega 3(Blooms build Australia's brand, company Baryj Essence) In the second group during 14 days before the start of the next menstruation to end of menstruation, the daily will be 30 drops (15 drops twice a day) Rose Oral Drop (Barij Essence company) Intervention 1: In the second group during 14 days before the start of the next menstruation to end of menstruation, the daily will be 30 drops (15 drops twice a day) Rose Oral Drop (Barij Essence company). Intervention 2: In the first group during the 14 days before the start of the next menstruation to menopause, a daily 500 mg of omega 3(Blooms build Australia's brand, company Baryj Essence). Treatment ‐ Drugs CONDITION: Premenstrual Syndrome. ; Premenstrual tension syndrome Premenstrual tension syndrome PRIMARY OUTCOME: Depression. Timepoint: During the next 14 days before the time of menarche to menopause. Method of measurement: Questionnaire Wong‐Baker faces pain rating scale(WBS). Pain Intensity. Timepoint: During The next 14 days before the time of menarche to menopause. Method of measurement: Questionnaire Wong‐Baker faces pain rating scale(WBS). Sleep Disorder. Timepoint: During the next 14 days before the time of menarche to menopause. Method of measurement: Questionnaire Wong‐Baker faces pain rating scale(WBS). Tension. Timepoint: During the next 14 days before the time of menarche to menopause. Method of measurement: Questionnaire Wong‐Baker faces pain rating scale(WBS). INCLUSION CRITERIA: INCLUSION CRITERIA: age between 18 to 30 years old; regular menstrual periods with long intervals of 21‐35 days; body mass index between 19.8 to 26; no history of smoking; not using contraceptive pills, anticonvulsants, antidepressants and vitamins during last 3 months; no history of mental illness and physical context (diabetes, hyperthyroidism and hypothyroidism, etc.); absence of symptoms such as tingling, Itching or abnormal vaginal discharge; no allergy to fish or fish oil or herbal medicines; no incident occurred in the past 6 months and diagnosis of premenstrual syndrome by using form syndrome diagnostic criteria for temporary. Exclusion criteria: unwillingness to continue their treatment and non‐compliance with medication orders during the study.